Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
$9.94
$3.49
$10.30
$579.72M2.311.43 million shs1.66 million shs
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
$0.00
$0.00
$0.00
$0.08
$2K1.024,274 shs8 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.16
-9.2%
$4.71
$4.01
$9.33
$75.32M1.29190,289 shs174,503 shs
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
$2.37
-1.3%
$2.44
$2.10
$3.80
$10.01M0.6914,020 shs28,004 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$3.57
+0.8%
$3.83
$0.52
$5.92
$234.04M1.85831,892 shs688,444 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
0.00%0.00%0.00%0.00%0.00%
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
0.00%0.00%0.00%+200.00%-99.37%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-0.22%-5.76%-10.72%-0.65%-15.34%
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
0.00%+0.84%+2.13%-7.90%-17.24%
Neuronetics, Inc. stock logo
STIM
Neuronetics
+1.14%+3.96%-6.60%-6.60%+91.35%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
N/AN/AN/AN/AN/AN/AN/AN/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
N/AN/AN/AN/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.5594 of 5 stars
3.63.00.00.00.60.00.0
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
3.4008 of 5 stars
3.55.00.00.02.51.70.6
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.691 of 5 stars
3.32.00.00.00.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
0.00
N/AN/AN/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
0.00
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67180.45% Upside
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
3.00
Buy$6.00153.16% Upside
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.67
Moderate Buy$5.5054.06% Upside

Current Analyst Ratings Breakdown

Latest APEN, SSKN, STIM, MOTS, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
$76.86M0.00N/AN/A$0.69 per share0.00
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
$319K0.01N/AN/A$1.74 per share0.00
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.64$0.39 per share10.60$3.41 per share1.22
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
$33.56M0.29N/AN/A$1.19 per share1.99
Neuronetics, Inc. stock logo
STIM
Neuronetics
$74.89M3.15N/AN/A$0.57 per share6.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
-$39.84M-$1.02N/AN/AN/A-51.84%-89.48%-33.76%N/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
-$12.87M-$15.64N/AN/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1045.8018.09N/A4.56%3.34%3.00%8/6/2025 (Estimated)
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
-$10.09M-$2.27N/AN/AN/A-27.22%-138.22%-24.37%8/13/2025 (Estimated)
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$43.71M-$1.310.00N/AN/A-53.67%-174.15%-38.41%8/11/2025 (Estimated)

Latest APEN, SSKN, STIM, MOTS, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/14/2025Q1 2025
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
-$0.56-$0.58-$0.02-$0.58$7.28 million$6.81 million
5/6/2025Q1 2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.13-$0.21-$0.08-$0.21$29.07 million$31.98 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
N/AN/AN/AN/AN/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
1.04
2.35
1.89
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
5.71
1.05
0.87
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.40
2.44
2.28

Institutional Ownership

CompanyInstitutional Ownership
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
76.01%
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
20.06%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
32.43%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%

Insider Ownership

CompanyInsider Ownership
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
17.30%
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
0.34%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
39.00%
Neuronetics, Inc. stock logo
STIM
Neuronetics
8.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
20257.97 million47.94 millionNot Optionable
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
305.77 million5.75 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
1204.17 million2.54 millionNot Optionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
18066.11 million60.36 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Apollo Endosurgery stock logo

Apollo Endosurgery NASDAQ:APEN

Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.

Motus GI stock logo

Motus GI NASDAQ:MOTS

$0.0003 0.00 (0.00%)
As of 07/10/2025

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.16 -0.42 (-9.17%)
Closing price 04:00 PM Eastern
Extended Trading
$4.29 +0.13 (+3.13%)
As of 05:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Strata Skin Sciences stock logo

Strata Skin Sciences NASDAQ:SSKN

$2.38 -0.03 (-1.04%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

Neuronetics stock logo

Neuronetics NASDAQ:STIM

$3.57 +0.03 (+0.85%)
Closing price 04:00 PM Eastern
Extended Trading
$3.53 -0.04 (-1.23%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.